Efficacy and safety results by menopausal status in monarchE: Adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2-high-risk early breast cancer

Basit Öğe Kaydı
dc.contributor.authorPaluch-Shimon, S.
dc.contributor.authorNeven, P.
dc.contributor.authorHuober, J.
dc.contributor.authorCicin, I.
dc.contributor.authorJiang, Z.
dc.contributor.authorGoetz, M. P.
dc.contributor.authorShimizu, C.
dc.date.accessioned2024-06-12T11:20:22Z
dc.date.available2024-06-12T11:20:22Z
dc.date.issued2022
dc.departmentTrakya Üniversitesien_US
dc.descriptionEuropean-Society-for-Medical-Oncology (ESMO) Breast Cancer Congress -- MAY 03-05, 2022 -- Berlin, GERMANYen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipEuropean Soc Med Oncolen_US
dc.identifier.doi10.1016/j.annonc.2022.03.079
dc.identifier.endpageS151en_US
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.startpageS151en_US
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2022.03.079
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25578
dc.identifier.volume33en_US
dc.identifier.wosWOS:000792494100065en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofAnnals Of Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keywords]en_US
dc.titleEfficacy and safety results by menopausal status in monarchE: Adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2-high-risk early breast canceren_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu